Dexmedetomidine	B:C0113293
Combined	O
With	O
Intravenous	O
Anesthetics	I:C0242904
in	O
Electroconvulsive	O

Dexmedetomidine	O
Combined	O
With	O
Intravenous	B:C0242904
Anesthetics	I:C0242904
in	O
Electroconvulsive	O

Dexmedetomidine	O
Combined	O
With	O
Intravenous	O
Anesthetics	I:C0242904
in	O
Electroconvulsive	B:C0013806

Therapy	I:C0013806
:	O
A	O
Meta-analysis	B:C0920317
and	O
Systematic	O
Review	I:C1955832
.	O

Therapy	I:C0013806
:	O
A	O
Meta-analysis	O
and	O
Systematic	B:C1955832
Review	I:C1955832
.	O

The	O
aim	O
of	O
this	O
study	B:C0008972
was	O
to	O
investigate	O
how	O
the	O
combined	O
use	O
of	O
dexmedetomidine	O
with	O
intravenous	O
anesthetics	I:C0242904
influences	O
seizure	O
duration	I:C0730597
and	O
circulatory	O
dynamics	O
in	O
electroconvulsive	O
therapy	I:C0013806
(	O
electroconvulsive	O
therapy	I:C0013806
)	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
how	O
the	O
combined	O
use	O
of	O
dexmedetomidine	B:C0113293
with	O
intravenous	O
anesthetics	I:C0242904
influences	O
seizure	O
duration	I:C0730597
and	O
circulatory	O
dynamics	O
in	O
electroconvulsive	O
therapy	I:C0013806
(	O
electroconvulsive	O
therapy	I:C0013806
)	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
how	O
the	O
combined	O
use	O
of	O
dexmedetomidine	O
with	O
intravenous	B:C0242904
anesthetics	I:C0242904
influences	O
seizure	O
duration	I:C0730597
and	O
circulatory	O
dynamics	O
in	O
electroconvulsive	O
therapy	I:C0013806
(	O
electroconvulsive	O
therapy	I:C0013806
)	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
how	O
the	O
combined	O
use	O
of	O
dexmedetomidine	O
with	O
intravenous	O
anesthetics	I:C0242904
influences	O
seizure	B:C0730597
duration	I:C0730597
and	O
circulatory	O
dynamics	O
in	O
electroconvulsive	O
therapy	I:C0013806
(	O
electroconvulsive	O
therapy	I:C0013806
)	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
how	O
the	O
combined	O
use	O
of	O
dexmedetomidine	O
with	O
intravenous	O
anesthetics	I:C0242904
influences	O
seizure	O
duration	I:C0730597
and	O
circulatory	O
dynamics	O
in	O
electroconvulsive	B:C0013806
therapy	I:C0013806
(	O
electroconvulsive	O
therapy	I:C0013806
)	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
how	O
the	O
combined	O
use	O
of	O
dexmedetomidine	O
with	O
intravenous	O
anesthetics	I:C0242904
influences	O
seizure	O
duration	I:C0730597
and	O
circulatory	O
dynamics	O
in	O
electroconvulsive	O
therapy	I:C0013806
(	O
electroconvulsive	B:C0013806
therapy	I:C0013806
)	O
.	O

A	O
literature	O
search	O
was	O
performed	O
to	O
identify	O
studies	B:C0008972
that	O
evaluated	O
the	O
effect	O
of	O
dexmedetomidine	O
on	O
motor	O
-	O
or	O
electroencephalogram	O
(	O
EEG	I:C0234552
)	I:C0234552
-	I:C0234552
based	I:C0234552
seizure	I:C0234552
duration	O
s	O
and	O
maximum	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
(	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
)	O
and	O
heart	O
rate	I:C0018810
(	O
heart	O
rate	I:C0018810
)	O
after	O
electroconvulsive	O
therapy	I:C0013806
.	O

A	O
literature	O
search	O
was	O
performed	O
to	O
identify	O
studies	O
that	O
evaluated	O
the	O
effect	O
of	O
dexmedetomidine	B:C0113293
on	O
motor	O
-	O
or	O
electroencephalogram	O
(	O
EEG	I:C0234552
)	I:C0234552
-	I:C0234552
based	I:C0234552
seizure	I:C0234552
duration	O
s	O
and	O
maximum	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
(	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
)	O
and	O
heart	O
rate	I:C0018810
(	O
heart	O
rate	I:C0018810
)	O
after	O
electroconvulsive	O
therapy	I:C0013806
.	O

A	O
literature	O
search	O
was	O
performed	O
to	O
identify	O
studies	O
that	O
evaluated	O
the	O
effect	O
of	O
dexmedetomidine	O
on	O
motor	B:C0751494
-	O
or	O
electroencephalogram	O
(	O
EEG	I:C0234552
)	I:C0234552
-	I:C0234552
based	I:C0234552
seizure	I:C0234552
duration	O
s	O
and	O
maximum	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
(	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
)	O
and	O
heart	O
rate	I:C0018810
(	O
heart	O
rate	I:C0018810
)	O
after	O
electroconvulsive	O
therapy	I:C0013806
.	O

A	O
literature	O
search	O
was	O
performed	O
to	O
identify	O
studies	O
that	O
evaluated	O
the	O
effect	O
of	O
dexmedetomidine	O
on	O
motor	O
-	O
or	O
electroencephalogram	B:C1527380
(	O
EEG	I:C0234552
)	I:C0234552
-	I:C0234552
based	I:C0234552
seizure	I:C0234552
duration	O
s	O
and	O
maximum	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
(	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
)	O
and	O
heart	O
rate	I:C0018810
(	O
heart	O
rate	I:C0018810
)	O
after	O
electroconvulsive	O
therapy	I:C0013806
.	O

A	O
literature	O
search	O
was	O
performed	O
to	O
identify	O
studies	O
that	O
evaluated	O
the	O
effect	O
of	O
dexmedetomidine	O
on	O
motor	O
-	O
or	O
electroencephalogram	O
(	B:C0234552
EEG	I:C0234552
)	I:C0234552
-	I:C0234552
based	I:C0234552
seizure	I:C0234552
duration	O
s	O
and	O
maximum	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
(	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
)	O
and	O
heart	O
rate	I:C0018810
(	O
heart	O
rate	I:C0018810
)	O
after	O
electroconvulsive	O
therapy	I:C0013806
.	O

A	O
literature	O
search	O
was	O
performed	O
to	O
identify	O
studies	O
that	O
evaluated	O
the	O
effect	O
of	O
dexmedetomidine	O
on	O
motor	O
-	O
or	O
electroencephalogram	O
(	O
EEG	I:C0234552
)	I:C0234552
-	I:C0234552
based	I:C0234552
seizure	I:C0234552
duration	B:C0730597
s	O
and	O
maximum	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
(	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
)	O
and	O
heart	O
rate	I:C0018810
(	O
heart	O
rate	I:C0018810
)	O
after	O
electroconvulsive	O
therapy	I:C0013806
.	O

A	O
literature	O
search	O
was	O
performed	O
to	O
identify	O
studies	O
that	O
evaluated	O
the	O
effect	O
of	O
dexmedetomidine	O
on	O
motor	O
-	O
or	O
electroencephalogram	O
(	O
EEG	I:C0234552
)	I:C0234552
-	I:C0234552
based	I:C0234552
seizure	I:C0234552
duration	O
s	O
and	O
maximum	O
mean	B:C0428886
arterial	I:C0428886
pressure	I:C0428886
(	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
)	O
and	O
heart	O
rate	I:C0018810
(	O
heart	O
rate	I:C0018810
)	O
after	O
electroconvulsive	O
therapy	I:C0013806
.	O

A	O
literature	O
search	O
was	O
performed	O
to	O
identify	O
studies	O
that	O
evaluated	O
the	O
effect	O
of	O
dexmedetomidine	O
on	O
motor	O
-	O
or	O
electroencephalogram	O
(	O
EEG	I:C0234552
)	I:C0234552
-	I:C0234552
based	I:C0234552
seizure	I:C0234552
duration	O
s	O
and	O
maximum	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
(	O
mean	B:C0428886
arterial	I:C0428886
pressure	I:C0428886
)	O
and	O
heart	O
rate	I:C0018810
(	O
heart	O
rate	I:C0018810
)	O
after	O
electroconvulsive	O
therapy	I:C0013806
.	O

A	O
literature	O
search	O
was	O
performed	O
to	O
identify	O
studies	O
that	O
evaluated	O
the	O
effect	O
of	O
dexmedetomidine	O
on	O
motor	O
-	O
or	O
electroencephalogram	O
(	O
EEG	I:C0234552
)	I:C0234552
-	I:C0234552
based	I:C0234552
seizure	I:C0234552
duration	O
s	O
and	O
maximum	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
(	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
)	O
and	O
heart	B:C0018810
rate	I:C0018810
(	O
heart	O
rate	I:C0018810
)	O
after	O
electroconvulsive	O
therapy	I:C0013806
.	O

A	O
literature	O
search	O
was	O
performed	O
to	O
identify	O
studies	O
that	O
evaluated	O
the	O
effect	O
of	O
dexmedetomidine	O
on	O
motor	O
-	O
or	O
electroencephalogram	O
(	O
EEG	I:C0234552
)	I:C0234552
-	I:C0234552
based	I:C0234552
seizure	I:C0234552
duration	O
s	O
and	O
maximum	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
(	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
)	O
and	O
heart	O
rate	I:C0018810
(	O
heart	B:C0018810
rate	I:C0018810
)	O
after	O
electroconvulsive	O
therapy	I:C0013806
.	O

A	O
literature	O
search	O
was	O
performed	O
to	O
identify	O
studies	O
that	O
evaluated	O
the	O
effect	O
of	O
dexmedetomidine	O
on	O
motor	O
-	O
or	O
electroencephalogram	O
(	O
EEG	I:C0234552
)	I:C0234552
-	I:C0234552
based	I:C0234552
seizure	I:C0234552
duration	O
s	O
and	O
maximum	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
(	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
)	O
and	O
heart	O
rate	I:C0018810
(	O
heart	O
rate	I:C0018810
)	O
after	O
electroconvulsive	B:C0013806
therapy	I:C0013806
.	O

Moreover	O
,	O
recovery	O
time	O
and	O
post	O
-	O
electroconvulsive	B:C0013806
therapy	I:C0013806
agitation	O
were	O
evaluated	O
.	O

Moreover	O
,	O
recovery	O
time	O
and	O
post	O
-	O
electroconvulsive	O
therapy	I:C0013806
agitation	B:C0085631
were	O
evaluated	O
.	O

Six	O
studies	B:C0008972
enrolling	O
166	O
patients	O
in	O
706	O
electroconvulsive	O
therapy	I:C0013806
sessions	O
were	O
included	O
.	O

Six	O
studies	O
enrolling	O
166	O
patients	O
in	O
706	O
electroconvulsive	B:C0013806
therapy	I:C0013806
sessions	O
were	O
included	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
motor	B:C0751494
or	O
EEG	O
seizure	I:C0234552
duration	O
between	O
dexmedetomidine	O
and	O
nondexmedetomidine	O
groups	O
[	O
motor	O
:	O
6	O
studies	O
;	O
mean	O
difference	O
(	O
MD	O
)	O
,	O
1.62	O
;	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
,	O
-	O
2.24	O
to	O
5.49	O
;	O
P	O
=	O
0.41	O
;	O
EEG	O
:	O
3	O
studies	O
;	O
MD	O
,	O
2.34	O
;	O
95	O
%	O
CI	O
,	O
-	O
6.03	O
to	O
10.71	O
;	O
P	O
=	O
0.58	O
]	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
motor	O
or	O
EEG	B:C0234552
seizure	I:C0234552
duration	O
between	O
dexmedetomidine	O
and	O
nondexmedetomidine	O
groups	O
[	O
motor	O
:	O
6	O
studies	O
;	O
mean	O
difference	O
(	O
MD	O
)	O
,	O
1.62	O
;	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
,	O
-	O
2.24	O
to	O
5.49	O
;	O
P	O
=	O
0.41	O
;	O
EEG	O
:	O
3	O
studies	O
;	O
MD	O
,	O
2.34	O
;	O
95	O
%	O
CI	O
,	O
-	O
6.03	O
to	O
10.71	O
;	O
P	O
=	O
0.58	O
]	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
motor	O
or	O
EEG	O
seizure	I:C0234552
duration	B:C0730597
between	O
dexmedetomidine	O
and	O
nondexmedetomidine	O
groups	O
[	O
motor	O
:	O
6	O
studies	O
;	O
mean	O
difference	O
(	O
MD	O
)	O
,	O
1.62	O
;	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
,	O
-	O
2.24	O
to	O
5.49	O
;	O
P	O
=	O
0.41	O
;	O
EEG	O
:	O
3	O
studies	O
;	O
MD	O
,	O
2.34	O
;	O
95	O
%	O
CI	O
,	O
-	O
6.03	O
to	O
10.71	O
;	O
P	O
=	O
0.58	O
]	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
motor	O
or	O
EEG	O
seizure	I:C0234552
duration	O
between	O
dexmedetomidine	O
and	O
nondexmedetomidine	O
groups	O
[	O
motor	B:C0751494
:	O
6	O
studies	O
;	O
mean	O
difference	O
(	O
MD	O
)	O
,	O
1.62	O
;	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
,	O
-	O
2.24	O
to	O
5.49	O
;	O
P	O
=	O
0.41	O
;	O
EEG	O
:	O
3	O
studies	O
;	O
MD	O
,	O
2.34	O
;	O
95	O
%	O
CI	O
,	O
-	O
6.03	O
to	O
10.71	O
;	O
P	O
=	O
0.58	O
]	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
motor	O
or	O
EEG	O
seizure	I:C0234552
duration	O
between	O
dexmedetomidine	O
and	O
nondexmedetomidine	O
groups	O
[	O
motor	O
:	O
6	O
studies	B:C0008972
;	O
mean	O
difference	O
(	O
MD	O
)	O
,	O
1.62	O
;	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
,	O
-	O
2.24	O
to	O
5.49	O
;	O
P	O
=	O
0.41	O
;	O
EEG	O
:	O
3	O
studies	O
;	O
MD	O
,	O
2.34	O
;	O
95	O
%	O
CI	O
,	O
-	O
6.03	O
to	O
10.71	O
;	O
P	O
=	O
0.58	O
]	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
motor	O
or	O
EEG	O
seizure	I:C0234552
duration	O
between	O
dexmedetomidine	O
and	O
nondexmedetomidine	O
groups	O
[	O
motor	O
:	O
6	O
studies	O
;	O
mean	O
difference	O
(	O
MD	O
)	O
,	O
1.62	O
;	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
,	O
-	O
2.24	O
to	O
5.49	O
;	O
P	O
=	O
0.41	O
;	O
EEG	O
:	O
3	O
studies	B:C0008972
;	O
MD	O
,	O
2.34	O
;	O
95	O
%	O
CI	O
,	O
-	O
6.03	O
to	O
10.71	O
;	O
P	O
=	O
0.58	O
]	O
.	O

Both	O
maximum	O
mean	B:C0428886
arterial	I:C0428886
pressure	I:C0428886
and	O
heart	O
rate	I:C0018810
after	O
electroconvulsive	O
therapy	I:C0013806
were	O
significantly	O
reduced	O
in	O
the	O
dexmedetomidine	O
group	O
(	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
:	O
6	O
studies	O
;	O
MD	O
,	O
-	O
4.83	O
;	O
95	O
%	O
CI	O
,	O
-	O
8.43	O
to	O
-	O
1.22	O
;	O
P	O
=	O
0.009	O
;	O
heart	O
rate	I:C0018810
:	O
6	O
studies	O
;	O
MD	O
,	O
-	O
6.68	O
;	O
95	O
%	O
CI	O
,	O
-	O
10.74	O
to	O
-	O
2.62	O
;	O
P	O
=	O
0.001	O
)	O
.	O

Both	O
maximum	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
and	O
heart	B:C0018810
rate	I:C0018810
after	O
electroconvulsive	O
therapy	I:C0013806
were	O
significantly	O
reduced	O
in	O
the	O
dexmedetomidine	O
group	O
(	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
:	O
6	O
studies	O
;	O
MD	O
,	O
-	O
4.83	O
;	O
95	O
%	O
CI	O
,	O
-	O
8.43	O
to	O
-	O
1.22	O
;	O
P	O
=	O
0.009	O
;	O
heart	O
rate	I:C0018810
:	O
6	O
studies	O
;	O
MD	O
,	O
-	O
6.68	O
;	O
95	O
%	O
CI	O
,	O
-	O
10.74	O
to	O
-	O
2.62	O
;	O
P	O
=	O
0.001	O
)	O
.	O

Both	O
maximum	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
and	O
heart	O
rate	I:C0018810
after	O
electroconvulsive	B:C0013806
therapy	I:C0013806
were	O
significantly	O
reduced	O
in	O
the	O
dexmedetomidine	O
group	O
(	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
:	O
6	O
studies	O
;	O
MD	O
,	O
-	O
4.83	O
;	O
95	O
%	O
CI	O
,	O
-	O
8.43	O
to	O
-	O
1.22	O
;	O
P	O
=	O
0.009	O
;	O
heart	O
rate	I:C0018810
:	O
6	O
studies	O
;	O
MD	O
,	O
-	O
6.68	O
;	O
95	O
%	O
CI	O
,	O
-	O
10.74	O
to	O
-	O
2.62	O
;	O
P	O
=	O
0.001	O
)	O
.	O

Both	O
maximum	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
and	O
heart	O
rate	I:C0018810
after	O
electroconvulsive	O
therapy	I:C0013806
were	O
significantly	O
reduced	O
in	O
the	O
dexmedetomidine	O
group	O
(	O
mean	B:C0428886
arterial	I:C0428886
pressure	I:C0428886
:	O
6	O
studies	O
;	O
MD	O
,	O
-	O
4.83	O
;	O
95	O
%	O
CI	O
,	O
-	O
8.43	O
to	O
-	O
1.22	O
;	O
P	O
=	O
0.009	O
;	O
heart	O
rate	I:C0018810
:	O
6	O
studies	O
;	O
MD	O
,	O
-	O
6.68	O
;	O
95	O
%	O
CI	O
,	O
-	O
10.74	O
to	O
-	O
2.62	O
;	O
P	O
=	O
0.001	O
)	O
.	O

Both	O
maximum	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
and	O
heart	O
rate	I:C0018810
after	O
electroconvulsive	O
therapy	I:C0013806
were	O
significantly	O
reduced	O
in	O
the	O
dexmedetomidine	O
group	O
(	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
:	O
6	O
studies	B:C0008972
;	O
MD	O
,	O
-	O
4.83	O
;	O
95	O
%	O
CI	O
,	O
-	O
8.43	O
to	O
-	O
1.22	O
;	O
P	O
=	O
0.009	O
;	O
heart	O
rate	I:C0018810
:	O
6	O
studies	O
;	O
MD	O
,	O
-	O
6.68	O
;	O
95	O
%	O
CI	O
,	O
-	O
10.74	O
to	O
-	O
2.62	O
;	O
P	O
=	O
0.001	O
)	O
.	O

Both	O
maximum	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
and	O
heart	O
rate	I:C0018810
after	O
electroconvulsive	O
therapy	I:C0013806
were	O
significantly	O
reduced	O
in	O
the	O
dexmedetomidine	O
group	O
(	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
:	O
6	O
studies	O
;	O
MD	O
,	O
-	O
4.83	O
;	O
95	O
%	O
CI	O
,	O
-	O
8.43	O
to	O
-	O
1.22	O
;	O
P	O
=	O
0.009	O
;	O
heart	B:C0018810
rate	I:C0018810
:	O
6	O
studies	O
;	O
MD	O
,	O
-	O
6.68	O
;	O
95	O
%	O
CI	O
,	O
-	O
10.74	O
to	O
-	O
2.62	O
;	O
P	O
=	O
0.001	O
)	O
.	O

Both	O
maximum	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
and	O
heart	O
rate	I:C0018810
after	O
electroconvulsive	O
therapy	I:C0013806
were	O
significantly	O
reduced	O
in	O
the	O
dexmedetomidine	O
group	O
(	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
:	O
6	O
studies	O
;	O
MD	O
,	O
-	O
4.83	O
;	O
95	O
%	O
CI	O
,	O
-	O
8.43	O
to	O
-	O
1.22	O
;	O
P	O
=	O
0.009	O
;	O
heart	O
rate	I:C0018810
:	O
6	O
studies	B:C0008972
;	O
MD	O
,	O
-	O
6.68	O
;	O
95	O
%	O
CI	O
,	O
-	O
10.74	O
to	O
-	O
2.62	O
;	O
P	O
=	O
0.001	O
)	O
.	O

Moreover	O
,	O
the	O
addition	O
of	O
dexmedetomidine	B:C0113293
did	O
not	O
significantly	O
prolong	O
recovery	O
time	O
when	O
the	O
reduced	O
-	O
dose	O
propofol	O
was	O
used	O
(	O
4	O
studies	O
;	O
MD	O
,	O
63.27	O
;	O
95	O
%	O
CI	O
,	O
-	O
15.41	O
to	O
141.96	O
;	O
P	O
=	O
0.12	O
)	O
.	O

Moreover	O
,	O
the	O
addition	O
of	O
dexmedetomidine	O
did	O
not	O
significantly	O
prolong	O
recovery	O
time	O
when	O
the	O
reduced	O
-	O
dose	O
propofol	B:C0033487
was	O
used	O
(	O
4	O
studies	O
;	O
MD	O
,	O
63.27	O
;	O
95	O
%	O
CI	O
,	O
-	O
15.41	O
to	O
141.96	O
;	O
P	O
=	O
0.12	O
)	O
.	O

Moreover	O
,	O
the	O
addition	O
of	O
dexmedetomidine	O
did	O
not	O
significantly	O
prolong	O
recovery	O
time	O
when	O
the	O
reduced	O
-	O
dose	O
propofol	O
was	O
used	O
(	O
4	O
studies	B:C0008972
;	O
MD	O
,	O
63.27	O
;	O
95	O
%	O
CI	O
,	O
-	O
15.41	O
to	O
141.96	O
;	O
P	O
=	O
0.12	O
)	O
.	O

The	O
use	O
of	O
dexmedetomidine	B:C0113293
in	O
electroconvulsive	O
therapy	I:C0013806
did	O
not	O
interfere	O
with	O
motor	O
and	O
EEG	O
seizure	I:C0234552
duration	O
s	O
but	O
could	O
reduce	O
maximum	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
and	O
heart	O
rate	I:C0018810
after	O
electroconvulsive	O
therapy	I:C0013806
.	O

The	O
use	O
of	O
dexmedetomidine	O
in	O
electroconvulsive	B:C0013806
therapy	I:C0013806
did	O
not	O
interfere	O
with	O
motor	O
and	O
EEG	O
seizure	I:C0234552
duration	O
s	O
but	O
could	O
reduce	O
maximum	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
and	O
heart	O
rate	I:C0018810
after	O
electroconvulsive	O
therapy	I:C0013806
.	O

The	O
use	O
of	O
dexmedetomidine	O
in	O
electroconvulsive	O
therapy	I:C0013806
did	O
not	O
interfere	O
with	O
motor	B:C0751494
and	O
EEG	O
seizure	I:C0234552
duration	O
s	O
but	O
could	O
reduce	O
maximum	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
and	O
heart	O
rate	I:C0018810
after	O
electroconvulsive	O
therapy	I:C0013806
.	O

The	O
use	O
of	O
dexmedetomidine	O
in	O
electroconvulsive	O
therapy	I:C0013806
did	O
not	O
interfere	O
with	O
motor	O
and	O
EEG	B:C0234552
seizure	I:C0234552
duration	O
s	O
but	O
could	O
reduce	O
maximum	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
and	O
heart	O
rate	I:C0018810
after	O
electroconvulsive	O
therapy	I:C0013806
.	O

The	O
use	O
of	O
dexmedetomidine	O
in	O
electroconvulsive	O
therapy	I:C0013806
did	O
not	O
interfere	O
with	O
motor	O
and	O
EEG	O
seizure	I:C0234552
duration	B:C0730597
s	O
but	O
could	O
reduce	O
maximum	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
and	O
heart	O
rate	I:C0018810
after	O
electroconvulsive	O
therapy	I:C0013806
.	O

The	O
use	O
of	O
dexmedetomidine	O
in	O
electroconvulsive	O
therapy	I:C0013806
did	O
not	O
interfere	O
with	O
motor	O
and	O
EEG	O
seizure	I:C0234552
duration	O
s	O
but	O
could	O
reduce	O
maximum	O
mean	B:C0428886
arterial	I:C0428886
pressure	I:C0428886
and	O
heart	O
rate	I:C0018810
after	O
electroconvulsive	O
therapy	I:C0013806
.	O

The	O
use	O
of	O
dexmedetomidine	O
in	O
electroconvulsive	O
therapy	I:C0013806
did	O
not	O
interfere	O
with	O
motor	O
and	O
EEG	O
seizure	I:C0234552
duration	O
s	O
but	O
could	O
reduce	O
maximum	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
and	O
heart	B:C0018810
rate	I:C0018810
after	O
electroconvulsive	O
therapy	I:C0013806
.	O

The	O
use	O
of	O
dexmedetomidine	O
in	O
electroconvulsive	O
therapy	I:C0013806
did	O
not	O
interfere	O
with	O
motor	O
and	O
EEG	O
seizure	I:C0234552
duration	O
s	O
but	O
could	O
reduce	O
maximum	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
and	O
heart	O
rate	I:C0018810
after	O
electroconvulsive	B:C0013806
therapy	I:C0013806
.	O

Besides	O
,	O
the	O
addition	O
of	O
dexmedetomidine	B:C0113293
in	O
electroconvulsive	O
therapy	I:C0013806
did	O
not	O
prolong	O
recovery	O
time	O
when	O
reduced	O
-	O
dose	O
propofol	O
was	O
used	O
.	O

Besides	O
,	O
the	O
addition	O
of	O
dexmedetomidine	O
in	O
electroconvulsive	B:C0013806
therapy	I:C0013806
did	O
not	O
prolong	O
recovery	O
time	O
when	O
reduced	O
-	O
dose	O
propofol	O
was	O
used	O
.	O

Besides	O
,	O
the	O
addition	O
of	O
dexmedetomidine	O
in	O
electroconvulsive	O
therapy	I:C0013806
did	O
not	O
prolong	O
recovery	O
time	O
when	O
reduced	O
-	O
dose	O
propofol	B:C0033487
was	O
used	O
.	O

It	O
might	O
be	O
worthwhile	O
for	O
patients	O
to	O
receive	O
dexmedetomidine	B:C0113293
before	O
the	O
induction	O
of	I:C0853212
anesthesia	I:C0853212
in	O
electroconvulsive	O
therapy	I:C0013806
.	O

It	O
might	O
be	O
worthwhile	O
for	O
patients	O
to	O
receive	O
dexmedetomidine	O
before	O
the	O
induction	B:C0853212
of	I:C0853212
anesthesia	I:C0853212
in	O
electroconvulsive	O
therapy	I:C0013806
.	O

It	O
might	O
be	O
worthwhile	O
for	O
patients	O
to	O
receive	O
dexmedetomidine	O
before	O
the	O
induction	O
of	I:C0853212
anesthesia	I:C0853212
in	O
electroconvulsive	B:C0013806
therapy	I:C0013806
.	O

